The biotechnology space spent the first half of 2016 in a sideways consolidation pattern but has been making a comeback in the second half of the year. There are a number of stocks in the space that are breaking out of bullish patterns or bouncing off moving average support and look to continue higher, but trading individual names in this highly volatile sector is not for everyone.
